Major Rectal Cancer Treatment Breakthrough

[vc_row][vc_column][vc_column_text]MAJOR RECTAL CANCER TREATMENT BREAKTHROUGH

A groundbreaking cancer trial at Sloan Kettering of a new drug, dostarlimab, has shown unprecedented results:  the cancer disappeared in 100% of the trial participants.

Although not for this particular program, National Cancer Center has funded post-doctoral cancer research at Memorial Sloan Kettering Cancer Center and we commend the scientists there for this keenly important advance.

National Cancer Center is currently funding a colorectal project at Nebraska University Medical Center.

For more information on our funding click here

To contribute to NCC’s research funding, please donate now

Full Article Link: https://www.cbsnews.com/miami/news/cancer-trial-shows-unprecedented-results-100-participants-see-cancer-disappear/?fbclid=IwAR0N6WNv5N_HTkgKoCIU_RPwFRaahYXC4rlSfPmKGqxqhqBIxhSxbfaIlhQ[/vc_column_text][/vc_column][/vc_row]